Taille et prévisions du marché de la nutrition entérale en Europe (2021-2031), part régionale, tendance et opportunité de croissance Couverture du rapport d\'analyse : par type de produit (nasogastrique, nasoentéral, à siroter et autres) et par pays
Formulations standardisées et produits de nutrition à base de plantes
On observe une forte demande de produits qui aident les consommateurs à gérer leur santé de manière proactive, en particulier ceux axés sur des besoins spécifiques en termes de niveaux d\'énergie, d\'immunité et de traitement des maladies. La fonctionnalité et les formulations spécifiques des produits entéraux n\'interfèrent pas avec les traitements existants des patients. Les formulations de macronutriments et de micronutriments de la nutrition entérale et leurs applications varient en fonction de la maladie considérée. Les formules de nutrition entérale isocalorique (1 kcal/ml) sont généralement prescrites pour atteindre des objectifs caloriques estimés ou mesurés, tandis que les formules à forte densité énergétique (> 1 kcal/ml) sont prescrites pour augmenter l\'apport calorique chez les patients souffrant de dysfonctionnement gastro-intestinal.
Les produits de nutrition entérale standardisés contiennent des constituants fixes et sont conçus pour répondre aux besoins nutritionnels moyens des patients, sachant que les besoins diffèrent selon les groupes d\'âge. Par exemple, Peptamen Formula (Nestlé) est la seule formule à base de peptides contenant 100 % de protéines de lactosérum hydrolysées enzymatiquement qui aide à surmonter l\'intolérance à l\'alimentation par sonde. Ces formules d\'alimentation par sonde sont des produits de nutrition entérale spécialisés conçus pour favoriser l\'absorption et surmonter les mécanismes de tolérance chez les personnes souffrant de troubles gastro-intestinaux.
L\'augmentation du nombre de personnes se tournant vers les aliments à base de plantes déclenche la demande de produits de nutrition à base de plantes dans le monde entier. Les gens deviennent de plus en plus intolérants aux ingrédients d\'origine artificielle/synthétique utilisés en plus grande quantité, ce qui peut entraîner des réactions indésirables. L\'enquête Innova Consumer Survey 2020 a montré que la santé, la diversité alimentaire, la durabilité et le goût sont parmi les principales raisons pour lesquelles les gens envisagent des alternatives à base de plantes. Abbott affirme que les consommateurs et les patients qui dépendent de l\'alimentation par sonde accordent également une grande attention à ces paramètres. Les entreprises du marché européen de la nutrition entérale capitalisent sur la préférence croissante pour les aliments sains dans divers groupes démographiques. En conséquence, des entreprises telles que Kate Farms, Functional Formularies et Real Food Blends ont développé des produits entéraux plus naturels et à base de plantes. En août 2021, Kate Farms a lancé le premier système d\'alimentation fermé délivrant des formules à base de plantes dans des sacs prêts à suspendre d\'une capacité de 1 L. Les formulations Kate Farms Standard 1.4 plain et Peptide 1.5 plain sont des produits à base de plantes, biologiques et denses en calories qui sont utilisés comme seule source de nutrition supplémentaire dans l\'alimentation par sonde. En septembre 2021, Abbott a lancé une gamme de protéines végétales et d\'ingrédients alimentaires biologiques pour les enfants et les adultes.
Par conséquent, les formulations fonctionnelles centrées sur le patient et les produits de nutrition à base de plantes sont les principales tendances émergentes sur le marché européen de la nutrition entérale.
Analyse du marché français de la nutrition entérale
Selon un article du Monde publié en mars 2023, la part de la population âgée de 60 ans ou plus en France devrait passer d\'environ 20 % en 2023 à environ 30 % d\'ici 2050. Le nombre de personnes âgées de 85 ans et plus augmenterait de près de 90 % entre 2030 et 2050. Les personnes âgées souffrent souvent de maladies chroniques telles que le diabète, les maladies cardiovasculaires et les troubles neurologiques (par exemple, accident vasculaire cérébral, maladie de Parkinson et maladie d\'Alzheimer). Ces conditions peuvent altérer la capacité de manger normalement, entraînant une malnutrition et nécessitant une alimentation entérale. Selon l\'Observatoire mondial du cancer, la France a signalé 483 568 nouveaux cas de cancer en 2022, et le nombre de cas prévalents (sur 5 ans) était de 1 494 814. Le cancer et la nutrition entérale sont étroitement liés. De nombreux patients atteints de cancer souffrent de malnutrition en raison de la maladie elle-même ou des traitements qu\'ils reçoivent, ce qui peut altérer leur capacité à manger et à absorber les nutriments essentiels.
Fresenius Kabir France propose une gamme diversifiée de produits de nutrition entérale prêts à l\'emploi tels que des aliments par sonde, des compléments nutritionnels oraux (ONS) et des produits en poudre. Pour les patients atteints de dysphagie, la société propose des produits à texture modifiée de différentes consistances pour répondre aux besoins individuels de différents patients.
Analyse de segmentation du rapport sur le marché européen de la nutrition entérale
Les principaux segments qui ont contribué à l\'élaboration de l\'analyse du marché européen de la nutrition entérale sont le type, le matériau et l\'utilisateur final.
En fonction du type de produit, le marché européen de la nutrition entérale est segmenté en produits nasogastriques, naso-entéraux, à siroter et autres. Français Le segment nasogastrique détenait la plus grande part de marché en 2023.
Quelques acteurs importants opérant sur le marché européen de la nutrition entérale sont Nestlé, Danone SA, Abbott Laboratories, Friesland Campina, Fresenius SE and Co. KGaA, B. Braun SE, Dr. Schär AG, Arla Food, Reckitt Benckiser, Perrigo Company PLC, Fonterra Co-operative Group Limited, Kate Farms et Nutritional Medicinals, LLC, entre autres.
Les entreprises lancent des produits et services nouveaux et innovants pour maintenir leur position sur le marché européen de la nutrition entérale. En novembre 2021, Abbott a lancé Similac 360 Total Care pour soutenir le système immunitaire, la santé digestive et le développement du cerveau. Similac 360 Total Care est la première et la seule préparation pour nourrissons aux États-Unis contenant un mélange de cinq HMO différents, que l\'on ne trouvait auparavant ensemble que dans le lait maternel. Cette formule est conçue pour fournir une nutrition nécessaire à la santé et au développement de l\'ensemble du bébé, y compris le développement du système immunitaire, du système digestif et du cerveau.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Europe Enteral Nutrition Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Pricing Analysis
4.4 Pricing Analysis for Sipping Formula
4.5 List of Key Market Players in Top 5 Market
4.5.1 Major Market players in Germany, France, United Kingdom
5. Europe Enteral Nutrition Market – Key Market Dynamics
5.1 Europe Enteral Nutrition Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Increasing Prevalence of Gastrointestinal Diseases
5.2.2 Rising Cases of Malnutrition and Premature Births
5.3 Market Restraints
5.3.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Feeding Systems
5.4 Market Opportunities
5.4.1 Strategic Initiatives by Key Market Players
5.5 Future Trends
5.5.1 Standardized Formulations and Plant-Based Nutrition Products
5.6 Impact of Drivers and Restraints:
6. Europe Enteral Nutrition Market Analysis
6.1 Europe Enteral Nutrition Market Revenue (US$ Million), 2021–2031
6.2 Europe Enteral Nutrition Market Forecast and Analysis
6.3 Enteral and Parenteral Market Value (%)
7. Europe Enteral Nutrition Market Analysis – by Product Type
7.1 Nasogastric
7.1.1 Overview
7.1.2 Nasogastric: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.1.3 Standard
7.1.3.1 Overview
7.1.3.2 Standard: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.1.4 Disease Specific
7.1.4.1 Overview
7.1.4.2 Disease Specific: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Nasoenteral
7.2.1 Overview
7.2.2 Nasoenteral: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Sipping
7.3.1 Overview
7.3.2 Sipping: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Enteral Nutrition Market – Country Analysis
8.1 Europe
8.1.1 Europe Enteral Nutrition Market Breakdown by Countries
8.1.2 Europe Enteral Nutrition Market Revenue and Forecast and Analysis – by Country
8.1.2.1 Europe Enteral Nutrition Market Revenue and Forecast and Analysis – by Country
8.1.2.2 Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.2.2.1 Germany: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.2.2 Germany: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.2.3 Germany: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.2.4 Germany: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.2.5 Germany: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.2.6 Germany: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.2.7 Germany: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.3 United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.2.3.1 United Kingdom: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.3.2 United Kingdom: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.3.3 United Kingdom: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.3.4 United Kingdom: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.3.5 United Kingdom: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.3.6 United Kingdom: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.3.7 United Kingdom: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.4 France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.2.4.1 France: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.4.2 France: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.4.3 France: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.4.4 France: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.4.5 France: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.4.6 France: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.4.7 France: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.5 Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.2.5.1 Italy: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.5.2 Italy: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.5.3 Italy: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.5.4 Italy: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.5.5 Italy: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.5.6 Italy: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.5.7 Italy: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.6 Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.2.6.1 Spain: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.6.2 Spain: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.6.3 Spain: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.6.4 Spain: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.6.5 Spain: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.6.6 Spain: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.6.7 Spain: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.7 Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.2.7.1 Czech Republic: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.7.2 Czech Republic: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.7.3 Czech Republic: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.7.4 Czech Republic: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.7.5 Czech Republic: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.7.6 Czech Republic: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.7.7 Czech Republic: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.8 Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.2.8.1 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.8.2 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.8.3 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.8.4 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.8.5 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.8.6 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.8.7 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Standard By End User
9. Industry Landscape
9.1 Overview
9.2 Growth Strategies in Europe Enteral Nutrition Market
9.3 Organic Growth Strategies
9.3.1 Overview
9.4 Inorganic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Nestle SA
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Danone SA
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Abbott Laboratories
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Royal FrieslandCampina NV
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Fresenius SE & Co KGaA
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 B Braun SE
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Reckitt Benckiser Group Plc
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Kate Farms Inc
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Dr Schar AG
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Fonterra Co-Operative Group Ltd
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
10.11 Arla Foods amba
10.11.1 Key Facts
10.11.2 Business Description
10.11.3 Products and Services
10.11.4 Financial Overview
10.11.5 SWOT Analysis
10.11.6 Key Developments
10.12 Perrigo Co Plc
10.12.1 Key Facts
10.12.2 Business Description
10.12.3 Products and Services
10.12.4 Financial Overview
10.12.5 SWOT Analysis
10.12.6 Key Developments
10.13 Charing Cross Scientific AS
10.13.1 Key Facts
10.13.2 Business Description
10.13.3 Products and Services
10.13.4 Financial Overview
10.13.5 SWOT Analysis
10.13.6 Key Developments
10.14 Bexen Medical
10.14.1 Key Facts
10.14.2 Business Description
10.14.3 Products and Services
10.14.4 Financial Overview
10.14.5 SWOT Analysis
10.14.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. Europe Enteral Nutrition Market Segmentation
Table 2. Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Table 3. Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 4. Sipping: Europe Enteral Nutrition Market, By Type (US$ Mn)
Table 5. Sipping: Europe Enteral Nutrition Market, By Standadr by Calories (US$ Mn)
Table 6. Sipping: Europe Enteral Nutrition Market, By Isocaloric (US$ Mn)
Table 7. Sipping: Europe Enteral Nutrition Market, By Hypercaloric (US$ Mn)
Table 8. Sipping: Europe Enteral Nutrition Market, By Standard by Type (US$ Mn)
Table 9. Sipping: Europe Enteral Nutrition Market, By Standard End User (US$ Mn)
Table 10. Sipping: Top 5 Europe Enteral Nutrition Markets (US$ Mn)
Table 11. Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Country
Table 12. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 13. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 14. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 15. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 16. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 17. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 18. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End User
Table 19. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 20. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 21. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 22. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 23. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 24. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 25. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End User
Table 26. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 27. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 28. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 29. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 30. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 31. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 32. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End User
Table 33. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 34. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 35. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 36. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 37. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 38. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 39. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End User
Table 40. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 41. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 42. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 43. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 44. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 45. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 46. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End User
Table 47. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 48. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 49. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 50. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 51. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 52. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 53. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End User
Table 54. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 55. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 56. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 57. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 58. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 59. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 60. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End User
Table 61. Recent Organic Growth Strategies in Europe Enteral Nutrition Market
Table 62. Recent Inorganic Growth Strategies in the Europe Enteral Nutrition Market
Table 63. Glossary of Terms, Europe Enteral Nutrition Market
List of Figures
Figure 1. Europe Enteral Nutrition Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Enteral Nutrition Market Revenue (US$ Million), 2021–2031
Figure 5. Europe Enteral Nutrition Market Share (%) – by Product Type, 2023 and 2031
Figure 6. Nasogastric: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Standard: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Disease Specific: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Nasoenteral: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Sipping: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Others: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Europe Enteral Nutrition Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 13. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Growth Strategies in Europe Enteral Nutrition Market
- Nestlé
- Danone S.A.
- Abbott Laboratories
- FrieslandCampina
- Fresenius SE and Co. KGaA
- B. Braun SE
- Dr. Schär AG
- Arla Food
- Reckitt Benckiser
- Perrigo Company PLC
- Fonterra Co-operative Group Limited
- Kate Farms
- Nutritional Medicinals, LLC
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe enteral nutrition market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe enteral nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution